Key facts: Sanofi will invest over $20 billion in the U.S. by 2030 to boost manufacturing and research, focusing on capacity expansion and partnerships. Tariffs are expected to have minimal impact in 2025.
قراءة أقل من دقيقة
- Sanofi will invest over $20 billion in the U.S. by 2030 to boost manufacturing and research, focusing on capacity expansion and partnerships. Tariffs are expected to have minimal impact in 2025.1
- Sanofi announced a new initiative to provide a month's supply of any of its insulin products for $35 to all U.S. patients with a valid prescription, regardless of their insurance status.2
- Sanofi is under investigation by the European Commission for potential antitrust violations, following unannounced inspections at its facilities in France and Germany.3